ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 20, 2024
Lowe’s Lowers Full Year 2024 Outlook on Weak DIY Sales
Image: Lowe’s shares have traded sideways since the beginning of 2022. Lowe’s updated its outlook for full year 2024 to account for “lower than expected DIY sales and a pressured macroeconomic environment.” Total 2024 sales are now expected in the range of $82.7-$83.2 billion (was $84-$85 billion), with comparable store sales expected to be down 3.5%-4% (was -2% to -3%). Adjusted operating income as a percentage of sales is targeted in the range of 12.4%-12.5% (was 12.6%-12.7%). Adjusted diluted earnings per share is expected in the range of $11.70-$11.90 (was $12.00-$12.30). Our $230 fair value estimate of Lowe’s remains unchanged at this time. Shares yield 1.9%.
Aug 19, 2024
Gilead Raises Non-GAAP Diluted Earnings Outlook for 2024
Image Source: Gilead. Looking to full-year 2024, Gilead expects total product sales of $27.1-$27.5 billion, unchanged from its prior outlook. Non-GAAP diluted earnings per share is now targeted in the range of $3.60-$3.90, compared to $3.45-$3.85 previously. At the end of the quarter, Gilead had $2.8 billion in cash and cash equivalents, which was down from the $8.4 billion mark as of the end of last year due to its $3.9 billion acquisition of CymaBay Therapeutics and a $1.75 billion repayment of senior notes. All told, we liked Gilead's second quarter results and its raised non-GAAP earnings per share guidance. Shares yield 4.2% at the time of this writing.
Aug 16, 2024
Deere’s Fiscal Third Quarter Results Reveal Challenging Conditions in the Global Agricultural and Construction Sectors
Image Source: Deere & Company. Looking to all of fiscal 2024, Deere continues to expect weak top-line performance across its portfolio. Production & Precision Agriculture net sales are expected to fall 20%-25%, Small Ag & Turf net sales are expected to decline at a similar pace, while Construction & Forestry net revenues are expected to drop 10%-15% on the year. Financial Services net income is targeted at $720 million for fiscal 2024. Deere ended the quarter with a hefty net debt position. Though Deere’s top line continues to face pressure, and its balance sheet isn’t as strong as we would like, management did reaffirm its net income outlook for fiscal 2024 at approximately $7 billion, which was above the consensus forecast. Shares of Deere yield 1.6%.
Aug 16, 2024
Dividend Increases/Decreases for the Week of August 16
Let's take a look at firms raising/lowering their dividends this week.
Aug 15, 2024
Walmart Raises Its Fiscal 2025 Outlook
Image Source: Walmart. Walmart’s adjusted earnings per share for fiscal 2025 is now targeted in the range of $2.35-$2.43 (was $2.23-$2.37). The company ended the quarter with total debt of $47 billion and cash and cash equivalents of $8.8 billion. Walmart hauled in $5.9 billion in free cash flow during the first six months of the year, well in excess of the $3.3 billion it paid in dividends over the same time period. We liked Walmart’s second quarter report, its raised outlook for fiscal 2025, and the company’s very healthy dividend. Shares yield 1.2% at the time of this writing.
Aug 15, 2024
Cisco’s Fiscal Fourth Quarter Results Exceed Expectations
Image Source: Cisco. Cisco ended its fiscal year with $31 billion in short- and long-term debt and $17.9 billion in cash and investments. Free cash flow of $10.2 billion during fiscal 2024 easily covered its cash dividends paid of $6.4 billion. We continue to like Cisco as an idea in the newsletter portfolios. Though it has a net debt position and revenue has been under pressure, it trades at a below-market multiple, pays a nice dividend, and is working aggressively to transform its business model into one that is more recurring in nature. Shares yield 3.5% at the time of this writing.
Aug 14, 2024
Home Depot’s Results Show Weaker Spending on Home Improvement Projects
Image: Home Depot’s shares have been choppy the past few years. Looking to fiscal 2024 guidance, which includes 53 weeks of operating results, Home Depot expects sales to advance 2.5%-3.5% on the year, and comparable sales to decline 3%-4% for the 52-week period compared to 2023. Adjusted operating margin rate is targeted between 13.8%-13.9%, while diluted earnings per share for the 53-week period is targeted to decline 2%-4%. Though Home Depot is navigating a weaker home-improvement spending environment, we like its dividend quite a bit, and the firm remains a key holding in the Dividend Growth Newsletter portfolio. Shares yield 2.6% at the time of this writing.
Aug 12, 2024
Procter & Gamble’s Organic Growth Fails to Impress
Image Source: P&G’s Citizenship Report. Procter & Gamble’s fiscal fourth quarter disappointed a number of investors as organic growth failed to outpace expectations. Looking to fiscal 2025, all-in sales growth is expected in the range of 2%-4%, with organic growth in the range of 3%-5%. P&G is targeting fiscal 2025 core net earnings per share growth in the range of 5%-7% versus fiscal 2024 core earnings per share of $6.59. We like P&G a lot, but shares are trading well above our fair value estimate.
Aug 12, 2024
Starbucks' Mixed Results Speak to Cautious Consumer Environment
Image Source: Starbucks' Global Impact Report. Starbucks’ fiscal third quarter results weren’t great. Consolidated revenue fell 1%, comparable store sales dropped, while the firm’s non-GAAP earnings per share faced additional pressures. During the fiscal third quarter, Starbucks opened 526 net new stores, ending the period with 39,477 stores -- broken down into 52% company-operated and 48% licensed. Stores in the U.S. and China made up 61% of its global portfolio. Starbucks is getting squeezed by a cautious consumer and higher labor costs, and while we like the company, we’re just not interested in shares at this time.
Aug 9, 2024
Eli Lilly Puts Up Strong Second Quarter Results, Raises Outlook
Image: Shares of Eli Lilly have been strong the past few years. Looking to 2024 full-year guidance, Eli Lilly raised its revenue expectations by $3 billion, upped its reported earnings per share guidance $2.05, to the range of $15.10-$15.60, and increased its non-GAAP earnings per share guidance by $2.60 to the range of $16.10-$16.60, above the consensus forecasts. We continue to like Eli Lilly’s product portfolio, particularly Mounjaro and Zepbound, and we include the Health Care Select Sector SPDR Fund, which includes Eli Lilly as its top weighting, in the Best Ideas Newsletter portfolio.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.